Lorenz H M, Hieronymus T, Grünke M, Manger B, Kalden J R
Department of Medicine III, University of Erlangen-Nuremberg, Germany.
Scand J Immunol. 1997 Jun;45(6):660-9. doi: 10.1046/j.1365-3083.1997.d01-443.x.
Interleukin (IL)-15 is a newly described cytokine with properties similar to IL-2. Even though it does not share sequence homology with IL-2, both cytokines bind to the same receptor with the noted exception of a cytokine specific alpha-chain. In this study the authors compared IL-2 and IL-15 to determine their ability to rescue short term activated lymphocytes (phytohaemagglutinin stimulation of peripheral blood mononuclear cells for 6 days, followed by expansion in medium containing IL-2 for 2 days) from apoptotic cell death. The authors found that both IL-2 and IL-15 can inhibit induction of apoptosis in this experimental model with similar time and dose kinetics. On mRNA or protein levels induction of pro- and anti-apoptotic gene products like fasL, bcl-2, or bax with minor effects on fas/Apo-1 or bcl-XL was observed under culture conditions with both IL-2 and IL-15. Next, it was found that phytohaemagglutinin (PHA) blasts were less responsive (in terms of cellular proliferation and prevention from apoptosis) to IL-2 if signals through the alpha-chain were blocked, with no effect on beta-chain specific monoclonal antibodies (MoAb). By contrast, IL-15 was less effective in induction of cellular proliferation and prevention of apoptosis if IL-2R beta-chain specific MoAb were added to cell cultures. Testing intracellular signalling induced by IL-2 or IL-15, the authors found identical changes in tyrosine phosphorylation patterns in PHA blasts cultured in medium or under IL-2 or IL-15 stimulation. By contrast, they found consistent differences if PHA stimulated peripheral blood mononuclear cells (PBMC) were expanded in medium containing IL-15 (instead of IL-2). These IL-15 expanded PHA blasts showed a significantly increased percentage of apoptosis after growth factor withdrawal. Furthermore, IL-2 was more efficient than IL-15 in rescuing IL-15 expanded PHA blasts from apoptosis. In IL-15 expanded PHA blasts expression of IL-2R alpha-chain was lower than that in IL-2 expanded PHA blasts. A model presenting a differential role for IL-2 and IL-15 in inhibition of apoptosis in vivo is discussed.
白细胞介素(IL)-15是一种新发现的细胞因子,其特性与IL-2相似。尽管它与IL-2没有序列同源性,但这两种细胞因子都能与相同的受体结合,唯一的例外是一种细胞因子特异性α链。在本研究中,作者比较了IL-2和IL-15,以确定它们挽救短期活化淋巴细胞(用植物血凝素刺激外周血单个核细胞6天,然后在含IL-2的培养基中扩增2天)免于凋亡性细胞死亡的能力。作者发现,在该实验模型中,IL-2和IL-15都能以相似的时间和剂量动力学抑制凋亡的诱导。在同时含有IL-2和IL-15的培养条件下,在mRNA或蛋白质水平上观察到促凋亡和抗凋亡基因产物如fasL、bcl-2或bax的诱导,而对fas/Apo-1或bcl-XL的影响较小。接下来发现,如果通过α链的信号被阻断,植物血凝素(PHA)母细胞对IL-2的反应性较低(就细胞增殖和防止凋亡而言),而β链特异性单克隆抗体(MoAb)则无影响。相比之下,如果将IL-2Rβ链特异性MoAb添加到细胞培养物中,IL-15在诱导细胞增殖和防止凋亡方面的效果较差。在测试由IL-2或IL-15诱导的细胞内信号传导时,作者发现在培养基中或在IL-2或IL-15刺激下培养的PHA母细胞中酪氨酸磷酸化模式有相同的变化。相比之下,如果PHA刺激的外周血单个核细胞(PBMC)在含IL-15(而非IL-2)的培养基中扩增,他们发现了一致的差异。这些IL-15扩增的PHA母细胞在生长因子撤除后凋亡百分比显著增加。此外,在挽救IL-15扩增的PHA母细胞免于凋亡方面,IL-2比IL-15更有效。在IL-15扩增的PHA母细胞中,IL-2Rα链的表达低于IL-2扩增的PHA母细胞。本文讨论了一个展示IL-2和IL-15在体内抑制凋亡中不同作用的模型。